RXi Pharmaceuticals reports Q1 earnings, highlights
WORCESTER, Mass. RXi Pharmaceuticals Corp., a biotech company developing drugs based on RNA interference, cited the publication of its in-licensed oral delivery technology in the journal Nature and the award of a grant from the Massachusetts Life Science Center to further support its research as highlights in its first-quarter 2009 financial report Friday.
The company reported a net loss of $4.2 million for the quarter, compared with $2.6 million in first quarter 2008.
NACDS, NCPA praise Senate’s inclusion of Medicaid reimbursement relief in healthcare reform proposal
ALEXANDRIA, Va. Two organizations have praised the Senate Finance Committee’s inclusion of Medicaid reimbursement relief in its healthcare reform proposals.
The National Association of Chain Drug Stores and the National Community Pharmacists Association hailed the inclusion of the policy by committee chairman Sens. Max Baucus, D-Mont., and Charles Grassley, R-Iowa.
“While this process is only beginning, and legislation is being crafted, we are pleased that chairman Baucus, senator Grassley and Finance Committee members have recognized the implications on patient access that threaten the ability of pharmacies to provide healthcare services to the neediest populations, especially those in rural and inner-city areas with higher percentages of Medicaid patients,” NACDS president and CEO Steven Anderson and NCPA executive VP and CEO Bruce Roberts said in a joint statement.
The proposal would increase the percentage of the federal upper limits from 250% to 300% of the weighted average of the most recent average manufacturer prices for pharmaceutically and therapeutically equivalent multiple-source drugs available nationally through commercial pharmacies.
Pfizer develops free medication program for unemployed Americans
NEW YORK Amid an economic environment of increasing unemployment, a large drug maker has started a program to offer medicines to unemployed Americans for free.
Pfizer announced the MAINTAIN plan to help eligible unemployed Americans and their families who have lost their health insurance continue receiving Pfizer medicines for free.
“We all know people who have been laid off recently and have lost their health insurance, making it difficult for them to pay for health care,” Pfizer regional president worldwide pharmaceuticals Jorge Puente stated. “We thought there must be some way we could help recently unemployed people who are taking Pfizer medicines to continue treatment during these challenging economic times.”
The program, whose name stands for Medicines Assistance for Those who Are In Need, will be open for enrollment through Dec. 31 for Americans who have become unemployed since Jan. 1, regardless of prior family income.